Ascendia
Nitprapa Siriwannakij, PhD, is a seasoned formulation scientist currently employed at Ascendia since August 2020. Prior experience includes serving as a Teaching Fellow at St. John's University, where Nitprapa instructed Pharm D students in pharmaceutics and physical pharmacy. A background in quality assurance was established at Novel Laboratories, Inc., focusing on training, change control, and quality document management. Previous roles also include formulation development at Chulalongkorn University, where Nitprapa analyzed physicochemical properties, and experience as a pharmacist, providing counseling and prescribing services. Academic credentials comprise a PhD in Pharmaceutical Sciences from St. John's University, an MEng in Pharmaceutical Engineering from Rutgers University, and a B.Sc. in Industrial and Physical Pharmacy and Cosmetic Sciences from Chulalongkorn University.
Ascendia
1 followers
Ascendia Pharmaceuticals offers a comprehensive suite of pre-formulation for preclinical- and clinical-stage drug candidates. It specializes in improving the solubility and bioavailability of poorly water-soluble drugs using its suite of nanotechnology platforms. Ascendia formulates products for injectable, oral, and topical routes ofadministration. The company has three technology platforms - EmulSol for producing nano-emulsions, AmorSol for creating amorphous solid dispersions, and NanoSol for formulating nano-particles.